Health

Medical technicians point at a patient's brain. A cannabis-based epilepsy treatment drug is now in the U.S. thanks to a young boy who suffered from seizures for years.
Health

Next Time You Hear About CBD-Based Treatments For Epilepsy, Think Of This Boy

Sam Vogelstein helped bring Epidiolex to the U.S.

Aug 15, 2018 - Tobias Coughlin-Bogue

Close up shot of two medical technician pointing at MRI x-ray of patient in clinic. Doctors analysing the xray images.( Photo by alvarez via Getty Images)

Medical technicians point at a patient's brain. A cannabis-based epilepsy treatment drug is now in the U.S. thanks to a young boy who suffered from seizures for years.

Close up shot of two medical technician pointing at MRI x-ray of patient in clinic. Doctors analysing the xray images.( Photo by alvarez via Getty Images)

Medical cannabis activists cheered the recent approval of Epidiolex by the FDA for its effectiveness in fighting two rare forms of epilepsy. The drug could be in pharmacies as soon as fall, as the DEA is set to reschedule it by September 23. The FDA’s decision made headlines, but what was overlooked was the fact that it was spurred by one family’s fight to access the medicine for their son. NPR recently profiled Sam Vogelstein, the epileptic boy whose quest for cannabis-based treatments ultimately led to Epidiolex being approved.

Vogelstein’s form of epilepsy, called epilepsy with myoclonic-absences, was so severe and persistent that he was having as many as 100 seizures a day at one point. As indicated by the name of his condition, his seizures were essentially like a light switch going off in his brain. When he had his first seizure, at four-years-old, his mother told NPR that “He did something that looked like a Judo bow after a match.”

In epilepsy with myoclonic-absences, the electricity in Vogelstein’s brain would shut off for a brief moment causing him to have all sorts of unfortunate accidents. “I don’t remember a lot of it really,” he told NPR. His mother, Evelyn Nussenbaum, said he’s fallen down stairs, slumped into his dinner plate, and cracked his head on a windowsill.

23376562 281153879041029 3268464684099750072 n Hops Discovered in India Could Help Bring Truly Legal CBD to Market
Photo of (Sam Vogelstein  Facebook)

They tried traditional epilepsy medications but said the side effects were too severe and the medicines weren’t very effective overall. Eventually, Nussbaum heard about a study in which scientists had successfully treated seizures in rodents with CBD in England.

Eventually, that led her to GW Pharmaceuticals and Epidiolex.

After bombarding the company with requests, they agreed to host Vogelstein for a two-week supervised trial in the U.K. It was, according to GW Pharmaceuticals, the first time they’d given Epidiolex to a patient, and the results were eye-opening.

“After one day his seizures were down to 30,” Nussenbaum told NPR. “After two days they were down to ten. After three days he had one seizure.”

But the family had to return to the U.S., so they began searching for a way to get Epidiolex back home. This led them to UCSF neurologist Dr. Roberta Cilio, who helped them petition the FDA under its compassionate use program. That petition was successful, and Vogelstein once again became a one-man clinical trial, this time in San Francisco.

The rest, as they say, is history.


Share This

Related Articles

Epidiolex, made by the United Kingdom-based GW Pharmaceuticals, might become the first FDA-approved drug for the treatment of epilepsy. Although cannabis has been used anecdotally for years to treat seizures, CBD and THC may finally get the regulatory stamp of approval.

This might be the first cannabis-based drug to get approved

Even if parents are treating their children with CBD according to state law, they risk losing custody for doing something federally illegal.

Maria Selva and her daughter Ali, during a trip to Disneyland in 2017. Maria is now suing after losing custody of her daughter for treating her seizures with CBD.

Federal laws have to change so Epidiolex can get to market. Will it impact other CBD products?

UNITED STATES - JUNE 04: Director of the DEA Chuck Rosenberg, then a US Attorney General of the Eastern District of Virginia, speaking at a news conference at the Department of Justice in Washington, D.C., June 4, 2007. Experts remain uncertain about whether the DEA will reclassify Epidiolex or CBD itself following FDA approval of Epidiolex for epilepsy on Monday, June 25. (Photo by Chris Kleponis/Bloomberg via Getty Images)

Comments

Stay in the loop

Exclusive deals, original content.
Delivered to you.